Log in

Relevant bibliographies by topics / Combined modality / Journal articles

To see the other types of publications on this topic, follow the link: Combined modality.

Journal articles on the topic 'Combined modality'

Author: Grafiati

Published: 2 June 2025

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Combined modality.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

McGinn, Cornelius J., and Timothy J. Kinsella. "Combined modality therapy." Current Opinion in Oncology 3, no. 6 (1991): 1049–54. http://dx.doi.org/10.1097/00001622-199112000-00013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Burke, Patricia A., Sally J. DeNardo, Laird A. Miers, David L. Kukis, and Gerald L. DeNardo. "Combined modality radioimmunotherapy." Cancer 94, S4 (2002): 1320–31. http://dx.doi.org/10.1002/cncr.10303.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Aisner, Joseph. "Update in Combined Modality." Chest 89, no. 4 (1986): 303S—305S. http://dx.doi.org/10.1378/chest.89.4_supplement.303s.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Kalsotra, Gopika. "Rhinocerebral Mycosis: Combined Modality Protocol." An International Journal of Otorhinolaryngology Clinics 1, no. 1 (2009): 49–54. http://dx.doi.org/10.5005/jp-journals-10003-1007.

Full text

Abstract:

Abstract Rhinocerebral mycosis is an invasive fungal infection which occurs primarily in the paranasal sinuses and progresses to involve the brain and/or the orbit. It is commonly seen in immunocompromised individuals and can be most effectively treated if diagnosed early, when it is limited to the nasal cavity and the paranasal sinuses. Even though it is acceptable that surgical debridement in combination with antifungal therapy can lead to high rate of cure, the surgical approach for intracranial extension is still a subject of debate. Twenty-four cases of rhinocerebral mycosis managed at ou

APA, Harvard, Vancouver, ISO, and other styles

5

Renner, Ian G., Patricia S. Gordon, Lori R. Rezabek-Kells, Mimi Chang, and Kristina K. Neagos. "Combined modality treatment in cholangiocarcinoma." American Journal of Gastroenterology 95, no. 9 (2000): 2485. http://dx.doi.org/10.1111/j.1572-0241.2000.02611.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Rosenberg, Steven A. "Combined-Modality Therapy of Cancer." New England Journal of Medicine 312, no. 23 (1985): 1512–14. http://dx.doi.org/10.1056/nejm198506063122309.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Giaccone, G. "Pleural mesothelioma: combined modality treatments." Annals of Oncology 13 (October 2002): 217–25. http://dx.doi.org/10.1093/annonc/mdf663.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

McLean, J. Nicolas, Sunjay R. Nunley, Carmen Klass, Charles Moore, Müller Susan, and A. S. Johnstone Peter. "Combined modality therapy of esthesioneuroblastoma." Otolaryngology–Head and Neck Surgery 136, no. 6 (2007): 998–1002. http://dx.doi.org/10.1016/j.otohns.2006.11.051.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Fuller, Donald B., and John S. Chambers. "Superior sulcus tumors: Combined modality." Annals of Thoracic Surgery 57, no. 5 (1994): 1133–39. http://dx.doi.org/10.1016/0003-4975(94)91343-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Juergens, Rosalyn A., and Arlene Forastiere. "Combined Modality Therapy of Esophageal Cancer." Journal of the National Comprehensive Cancer Network 6, no. 9 (2008): 851–61. http://dx.doi.org/10.6004/jnccn.2008.0063.

Full text

Abstract:

Esophageal cancer is a deadly disease. Only one third of patients with localized disease experience long-term survival. Over the past 20 years, investigators have evaluated neoadjuvant strategies to improve the outcomes of surgical management. Chemotherapy and radiation have been evaluated individually and in combination for preoperative management of patients with localized esophageal cancer. This article provides a critical review of the data on multimodality approaches to the management of esophageal cancer.

APA, Harvard, Vancouver, ISO, and other styles

11

Mierzwa, Michelle L., Mukesh K. Nyati, Meredith A. Morgan, and Theodore S. Lawrence. "Recent Advances in Combined Modality Therapy." Oncologist 15, no. 4 (2010): 372–81. http://dx.doi.org/10.1634/theoncologist.2009-s105.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

&NA;. "Combined modality therapy for pancreatic cancer." Inpharma Weekly &NA;, no. 889 (1993): 19. http://dx.doi.org/10.2165/00128413-199308890-00045.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Mishra, Chitaranjan, Usha Kim, and Mulasthanam Sai Dheera. "Combined Treatment Modality for Phthiriasis Palpebrarum." Indian Journal of Medical Microbiology 37, no. 2 (2019): 296–97. http://dx.doi.org/10.4103/ijmm.ijmm_19_251.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Falkson, Geoffrey, Carla I. Falkson, and Conrad B. Falkson. "Combined modality treatment of gastrointestinal cancer." Current Opinion in Oncology 5, no. 4 (1993): 710–18. http://dx.doi.org/10.1097/00001622-199307000-00016.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Ackerman, Ida, and Gillian M. Thomas. "Combined modality therapy for gynecologic cancer." Current Opinion in Oncology 7, no. 5 (1995): 466–72. http://dx.doi.org/10.1097/00001622-199509000-00013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Pisters, Peter W. T., and Brian O'Sullivan. "Retroperitoneal sarcomas: combined modality treatment approaches." Current Opinion in Oncology 14, no. 4 (2002): 400–405. http://dx.doi.org/10.1097/00001622-200207000-00006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Tordiglione, Michele, Maurizio Kalli, Vittorio Vavassori, and Roberto Luraghi. "Combined Modality Treatment for Esophageal Cancer." Tumori Journal 84, no. 2 (1998): 252–58. http://dx.doi.org/10.1177/030089169808400226.

Full text

Abstract:

We have performed a review of recent literature about combined modality therapy in esophageal cancer. Radiobiological principles and radio-chemotherapy interactions modalities in clinical experiences have been considered. Therapeutic schedules, modalities of implementation, and the most relevant clinical results obtained by the major clinical research groups have been emphasized. We also comment on the current role of surgery and on the clinical questions arising in combined radio-chemotherapy treatment.

APA, Harvard, Vancouver, ISO, and other styles

18

Tilgen, W., U. Zierott, U. Keilholz, G. Longère, C. Scheibenbogen, and D. Petzoldt. "Combined modality therapy of metastatic melanoma." Melanoma Research 3, no. 1 (1993): 51. http://dx.doi.org/10.1097/00008390-199303000-00177.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Sobat, H., A. Juretic, and M. Samija. "Combined modality therapy of rectal cancers." Annals of Oncology 10 (1999): S99—S104. http://dx.doi.org/10.1093/annonc/10.suppl_6.s99.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Zhu, Andrew X., and Christopher G. Willett. "Combined modality treatment for rectal cancer." Seminars in Oncology 32, no. 1 (2005): 103–12. http://dx.doi.org/10.1053/j.seminoncol.2004.09.032.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Tonlaar, Nathan, Suisui Song, Julian C. Hong, et al. "Combined-modality Therapy for Rectal Cancer." American Journal of Clinical Oncology 37, no. 2 (2014): 122–25. http://dx.doi.org/10.1097/coc.0b013e318271ae2c.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Maughan, T. S., and T. D. L. Crosby. "Combined modality treatment in oesophageal carcinoma." Clinical Oncology 10, no. 6 (1998): 354–55. http://dx.doi.org/10.1016/s0936-6555(98)80028-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Bodey, Rachel K., Phil M. Evans, and Glenn D. Flux. "Spatial aspects of combined modality radiotherapy." Radiotherapy and Oncology 77, no. 3 (2005): 301–9. http://dx.doi.org/10.1016/j.radonc.2005.10.006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Vokes, Everett E. "Combined modality therapy of solid tumours." Lancet 349 (May 1997): S4—S6. http://dx.doi.org/10.1016/s0140-6736(97)90011-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Chamberlain, Marc C. "Combined-modality Treatment of Leptomeningeal Gliomatosis." Neurosurgery 52, no. 2 (2003): 324–30. http://dx.doi.org/10.1227/01.neu.0000043929.31608.62.

Full text

Abstract:

Abstract OBJECTIVE Leptomeningeal gliomatosis (LG) is a clinically uncommon metastatic complication of high-grade gliomas (HGGs), for which there is no consensus regarding treatment. The goal of this study was to determine the toxicity and response rate of combined-modality therapy for the treatment of patients with HGGs and LG. METHODS Eighteen patients (10 men and 8 women), ranging in age from 28 to 70 years (median, 38 yr), with clinically, neuroradiologically, and cytologically documented LG received intraventricular chemotherapy. Tumor histological types included anaplastic astrocytoma (1

APA, Harvard, Vancouver, ISO, and other styles

26

Karpeh, Martin S., and David P. Kelsen. "Combined Modality Therapy of Gastric Cancer." Surgical Oncology Clinics of North America 6, no. 4 (1997): 741–47. http://dx.doi.org/10.1016/s1055-3207(18)30301-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Blanke, Charles D., Hak Choy, and Steven D. Leach. "Combined modality therapy for esophageal cancer." Seminars in Radiation Oncology 7, no. 3 (1997): 15–23. http://dx.doi.org/10.1016/s1053-4296(97)80056-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Sause, Willam T. "Combined modality therapy for lung cancer." Lung Cancer 18 (August 1997): 77–78. http://dx.doi.org/10.1016/s0169-5002(97)83906-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Dottino, P. R., C. M. Johnston, A. M. Beddoe, J. Mandelli, and C. J. Cohen. "Combined modality treatment in cervical cancer." Gynecologic Oncology 40, no. 2 (1991): 191. http://dx.doi.org/10.1016/0090-8258(91)90212-n.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Gamliel, Ziv, and Mark J. Krasna. "Combined modality therapy for esophageal cancer." Current Oncology Reports 1, no. 2 (1999): 149–54. http://dx.doi.org/10.1007/s11912-999-0026-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

MINSKY, B. "Combined modality therapy for esophageal cancer." Seminars in Oncology 30 (August 2003): 46–55. http://dx.doi.org/10.1016/s0093-7754(03)00272-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

TSAI, J. "Combined modality therapy for pancreatic cancer." Seminars in Oncology 30 (August 2003): 71–79. http://dx.doi.org/10.1016/s0093-7754(03)00273-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Lombardi, Lucia, Michele Troiano, Nicola Silvestris, et al. "Combined modality treatments in pancreatic cancer." Expert Opinion on Therapeutic Targets 16, sup2 (2012): S71—S81. http://dx.doi.org/10.1517/14728222.2012.662959.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Gibson, Michael K., and Arlene A. Forastiere. "Combined-Modality Therapy for Esophageal Cancer." Cancer Journal 9, no. 4 (2003): 238–40. http://dx.doi.org/10.1097/00130404-200307000-00003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Roelofsen, F., and H. Bartelink. "Combined Modality Treatment of Anal Carcinoma." Oncologist 3, no. 6 (1998): 413–18. http://dx.doi.org/10.1634/theoncologist.3-6-413.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Baglan, R. J. "Combined modality therapy for lung cancer." Journal of Clinical Oncology 16, no. 2 (1998): 807–8. http://dx.doi.org/10.1200/jco.1998.16.2.807.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Baumann, M., T. Herrmann, and H. D. Thames. "Combined modality in advanced Hodgkin's disease." Journal of Clinical Oncology 16, no. 8 (1998): 2893–94. http://dx.doi.org/10.1200/jco.1998.16.8.2893.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Callery, Mark P. "Combined modality therapy for rectal cancer." Gastroenterology 128, no. 5 (2005): 1516–17. http://dx.doi.org/10.1053/j.gastro.2005.03.069.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Einhorn, L. H. "Combined modality therapy in esophageal cancer." Journal of Clinical Oncology 8, no. 7 (1990): 1286–87. http://dx.doi.org/10.1200/jco.1990.8.7.1286.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Patel, Sagar A., David P. Ryan, and Theodore S. Hong. "Combined Modality Therapy for Rectal Cancer." Cancer Journal 22, no. 3 (2016): 211–17. http://dx.doi.org/10.1097/ppo.0000000000000193.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Klimm, Beate, and Andreas Engert. "Combined Modality Treatment of Hodgkin’s Lymphoma." Cancer Journal 15, no. 2 (2009): 143–49. http://dx.doi.org/10.1097/ppo.0b013e31819e31ba.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Minsky, Bruce D., Claus Röedel, and Vincenzo Valentini. "Combined Modality Therapy for Rectal Cancer." Cancer Journal 16, no. 3 (2010): 253–61. http://dx.doi.org/10.1097/ppo.0b013e3181e0761c.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Halberg, F., W. Warm, L. Fippin, et al. "Medulloblastoma: Results with combined modality therapy." International Journal of Radiation Oncology*Biology*Physics 17 (January 1989): 136. http://dx.doi.org/10.1016/0360-3016(89)90671-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Fraunholz, Ingeborg, Daniela Rabeneck, Christian Weiß, and Claus Rödel. "Combined-Modality Treatment for Anal Cancer." Strahlentherapie und Onkologie 186, no. 7 (2010): 361–66. http://dx.doi.org/10.1007/s00066-010-2162-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Raut, Chandrajit P., and Peter W. T. Pisters. "Retroperitoneal sarcomas: Combined-modality treatment approaches." Journal of Surgical Oncology 94, no. 1 (2006): 81–87. http://dx.doi.org/10.1002/jso.20543.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Raghavan, Derek. "Combined modality treatment of bladder cancer." International Journal of Radiation Oncology*Biology*Physics 19 (January 1990): 103. http://dx.doi.org/10.1016/0360-3016(90)90613-o.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Yao, James C., Paul F. Mansfield, Peter W. T. Pisters, et al. "Combined-modality therapy for gastric cancer." Seminars in Surgical Oncology 21, no. 4 (2003): 223–27. http://dx.doi.org/10.1002/ssu.10040.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

THIELECKE, HAYO. "Control effects as a modality." Journal of Functional Programming 19, no. 1 (2009): 17–26. http://dx.doi.org/10.1017/s0956796808006734.

Full text

Abstract:

AbstractWe combine ideas from types for continuations, effect systems and monads in a very simple setting by defining a version of classical propositional logic in which double-negation elimination is combined with a modality. The modality corresponds to control effects, and it includes a form of effect masking. Erasing the modality from formulas gives classical logic. On the other hand, the logic is conservative over intuitionistic logic.

APA, Harvard, Vancouver, ISO, and other styles

49

Pauwels, Bea, Annelies E. C. Korst, Filip Lardon, and Jan B. Vermorken. "Combined Modality Therapy of Gemcitabine and Radiation." Oncologist 10, no. 1 (2005): 34–51. http://dx.doi.org/10.1634/theoncologist.10-1-34.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Thomas, Charles Richard. "Interview: Combined-modality therapy in gastrointestinal cancers." Colorectal Cancer 2, no. 1 (2013): 27–30. http://dx.doi.org/10.2217/crc.13.1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!